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Contrast media volume is significantly related to patient lung 
volume during CT pulmonary angiography when employing a 
patient-specific contrast protocol 
 
Abstract  
Purpose: The purpose of this study is to investigate the relationship between contrast 
media volume and patient lung volume when employing a patient-specific contrast media 
formula during pulmonary computed tomography angiography (CTA). 
 
Materials and methods: IRB approved this retrospective study. CTA of the pulmonary 
arteries was performed on 200 patients with suspected pulmonary embolism (PE). The 
contrast media volume (CMV) was calculted by employing a patient-specific contrast 
formula. Lung volume was quantified employing semi-automated lung software that 
calculated lung volumes (intellispace -Philips). The mean cross-sectional opacification profile 
of central and peripheral pulmonary arteries and veins were measured for each patient and 
arteriovenous contrast ratio (AVCR) calculated for each lung segment.  Mean body mass 
index (BMI) and lung volume were quantified. Receiver operating (ROC) and visual grading 
characteristics (VGC) measured reader confidence in emboli detection and image quality 
respectively. Inter and intra-observer variations were investigated employing Cohen’s kappa 
methodology.  
 
Results: Results showed that the mean pulmonary arterial opacification of the main 
pulmonary circulation (343.88±73HU), right lung; upper (316.51±23HU), middle 
(312.5±39HU) and lower (315.23±65HU) lobes and left; upper (318.76±83HU), and lower 
(321.91±12HU) lobes. The mean venous opacification of all pulmonary veins was below 
182±72HU. AVCR was observed at all anatomic locations (p<0.0002) where this ratio was 
calculated. Moreover, larger volumes of contrast significantly correlated with larger lung 
volumes (r=0.89, p<0.03) and radiation dose (p<0.03). VGC and ROC analysis demonstrated 
increased area under the curve: 0.831 and 0.99 respectively (p<0.02). Inter-observer 
variation was observed as excellent (κ = 0.71). We conclude that increased CMV is 
significantly correlated to increased patient lung volume and radiation dose when 
employing a patient-specific contrast formula. The effects patient habitus is highlighted. 
 
Key Words: contrast media, contrast protocol, computed tomography, lung volume, 
pulmonary angiography 
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Introduction 
Although the gold standard in pulmonary embolism diagnosis is still 
angiopulmonography, computed tomography pulmonary angiography (CTPA) protocols 
have witnessed a surge in thrombus detection at a specificity and sensitivity approaching 
100% with additional benefits of non-invasiveness and accessibility (1).  Since this efficacy is 
largely dependent on effective contrast media volume (CMV) administration, studies have 
been extensively conducted on contrast administration protocols (2-8).  These studies have 
found that visualization of the pulmonary vasculature is significantly improved when using a 
simple patient-specific formula (1, 7, 9), which also allows CMV to be reduced along with the 
potential risk of contrast induced nephropathy (1). 
Studies performed on adult patients with normal pulmonary functioning 
demonstrated an air/tissue relationship approaching a 7:3 ratio of air to lung parenchyma 
(10); other studies noticed that an increase in total lung volume is concomitant with an 
increase in the volume of pulmonary blood and pulmonary extravascular water (11).  To our 
knowledge, there have been no studies to date that compares CMV with patient lung 
volume employing a reduced patient-specific formula.  The aim of the study is to investigate 
the relationship between CMV and patient lung volume when employing a patient-specific 
contrast media formula during CTPA. Our results could be used as a foundation for further 
research on lung volume specific CTPA protocols.  
 
Materials and Methods 
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Study Population 
 The institutional review board approved this study and written informed consent 
was waived since all studies were clinically indicated and patient data was evaluated 
retrospectively.  Two hundred consecutive patients with high clinical suspicion of acute 
pulmonary embolism (PE) were examined over a 6-month period between August 2018 and 
January 2019. The indication for CTPA was suspected PE based on clinical information (chest 
pain, dyspnea, hypoxia, calf pain or known deep vein thrombosis (DVT), risk factors for PE) 
and/or laboratory information (positive d-dimer > 0.8 mg/L).  All patients with a positive PE 
in this study received anticoagulation therapy and due to the nature of the suspected 
condition, all patients were scanned. Inclusion criteria were patient with suspected PE as 
per the criteria mentioned above, who underwent CTPA. Patient with no suspected PE, or 
patient with PE who did not undergo CTPA were excluded.  There were no patients in the 
study that had renal insufficiency and/or contra-indications to iodinated contrast media. 
The diagnosis and treatment were in adherence with amercan collage of cardiology (ACC) 
guidelines for the diagnosis and managent of pulmonary embolism. 
Ethical approval: 
 All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the American university of Beirut’s institutional 
review board (IRB) and with the 1964 Helsinki declaration and its later amendments or 
comparable ethical standards. Informed consent was waived since all studies were clinically 
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indicated, patient data contained no identifiable information and was evaluated 
retrospectively. 
Image Acquisition 
CTPA was performed using a 256-channel computed tomography scanner (Philips 
Brilliance iCT, Philips Healthcare, The Netherlands).  Patients were positioned supine with 
arms resting on the gantry above the head.  Anterior-posterior scout were performed, with 
a scan range from the apices (2 cm above the 1st rib) to the diaphragm (2 cm below the 
lowest costophrenic recess).  Breath-hold, with a mouth open breathing technique were 
employed in order to reduce hyperventilation and Valsalva. Scan range was from the lung 
apices to the costophrenic angles.  CT scan parameters employed in each protocol were: 
detector width of 256×0.625 mm, pitch of 0.981:1 ratio, rotation time of 0.27 sec, 100 kVp, 
140 mA, with x,y and z-axis modulation (DoseRight), craniocaudal scan direction and model 
based iterative reconstruction (IMR2).  
 
Contrast Media Administration 
Contrast Bolus Geometry 
 Vessel opacification for all cases was measured by placing a region of interest (ROI) 
over the main pulmonary trunk.  A time attenuation curve in Hounsfield units (HU) was 
calculated and the desired peak opacification was recorded. The patient-specific protocol 
employed the test bolus technique (12) where the ROI was plotted inside the main 
pulmonary trunk with a small amount of contrast material (5 mL) injected at the same rate 
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as the main bolus.  This ROI assessed the time to peak (TTP) and determined the 
arteriovenous circulation time for pulmonary vasculature (12-14).  
 
Contrast Media Acquisition 
Contrast and saline chaser were injected with an automated dual barrel power 
injector (CT Emotion, Ullrich, Germany) via a 20G venous catheter in the right arm (15, 16).  
The patient-specific contrast formula employed iodinated contrast (Omnipaque 350 
mgI/mL; General Electric, USA) intravenously injected at a flow rate of 4.5 mL/s. Contrast 
media volume was calculated according to an empirically derived formula (17): CV=(ST+TTP-
OVWP)×FR. Where ST is the scan time (s), TTP (s) is as described above, OVWP is the optimal 
venous washout phase (6s), and FR is the flow rate (mL/s). ST differs for each patient based 
on the distance between the apices and diaphragm of the thorax. Patients were excluded if 
they were unable to have a right sided injection site in the cubital fossa with a flow rate of 
4.5 mL/s. 
 
Radiation Dose Measurement 
 For each of the CT scans, individual effective dose (Eff [mSv]) was calculated from the 
dose-length products (DLP [mGy × cm]), which were recorded from the patient protocol. A 
normalized conversion factor (k [mSv / mGy × cm]) for the chest—0.014 mSv/mGy × cm—
was used to calculate the Eff (18): Eff = DLP x k  (4). 
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Image assessment 
 Technical inclusion criteria ensuring correct scan range and anatomical inclusion of 
the origin, pathway and termination of the pulmonary vasculature were applied to all cases 
by two expert radiologists (not included in the study proper).  Quantitative measurements 
of all images were performed using a primary reporting workstation (Intellispace,Philips 
Healthcare, Netherlands) with a GSDF-calibrated 3 megapixel monitor. Illumination was 
adjusted at 25 to 32 lux (19), with a calibrated photometer (chroma meter CL-200).  
 
Quantitative Analysis 
 Opacification in HU was measured for all cases in the trans-axial images within the 
largest circular ROI that would fit within the lumen and exclude the vessel wall. The mean 
cross-sectional opacification profile of 8 central segments and 11 peripheral pulmonary 
arteries were measured.  In cases where PE was identified, care was taken not to include the 
emboli within the measurements.  Arterial and venous measurements took place at the 
heart, pulmonary trunk, segmental and sub segmental pulmonary vasculature and each 
measurement was no less than 2 mm in diameter (Figure 1).  The location of the arteries 
and veins were as follows:central pulmonary vasculature (trunk, right and left pulmonary 
arteries and left superior and inferior pulmonary veins); pulmonary segments; right upper 
lobe (anterior and posterior), right middle lobe (lateral and medial), right lower lobe 
(anterior and posterior basal), left upper lobe (apico-posterior and inferior lingular) and left 
lower lobe (anteromedial basal and posterior basal); superior vena cava (SVC). 
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Adjacent to the arterial pathways, the venous measurements were performed in the 
same axial plane.  Image contrast between arteries and veins was expressed as a ratio of HU 
values (artery/vein) at each anatomical level and denoted as the arteriovenous contrast 
ratio AVCR (20).  
Lung volume parenchyma and airway volumes were measured by quantitative 
volumetric analysis (Figure 2) on the CTPA imaging sequence using the Philips Intellispace 
lung segmentation software (v6.0.3.12200, Best, The Netherlands).  
  
 
Figure 1: anatomical location of measurements of the pulmonary vasculature 
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Figure 2: Lung volume analysis  
 
Diagnostic Efficacy 
 The multi-reader analysis consisted of two cardiothoracic radiologists who had been 
certified by the American Board of Radiology and The Royal College of Radiologists for a 
mean number of 8.9 years (minimum, 3 years; maximum, 18 years). All reviewers were 
specialists in cardiothoracic imaging and each observer was allowed to manipulate the 
window level of the images.  
 
ROC Analysis 
Receiver operating characteristic (ROC) methodology was employed to illustrate 
radiologist confidence intervals to detect pathology. A score of 1 to 2 was assigned to each 
image, where 1 indicates positive for pathology detection and 2 indicates negative for 
pathology detection of PE. All cases were randomly allotted with the number of normal 
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(n=87) and abnormal (n=113) cases.  The abnormal cases demonstrated an array of vascular 
disease that were defined by two radiologists’ reports (based on complete patient series, 
previous and subsequent examinations and clinical indications). All pathology was visible on 
the transaxial images and the prevalence of pathology was not revealed to the observers. 
Technical criteria ensuring correct scan range and anatomical inclusion were considered 
(not included in the study proper) to ensure that all images displayed an acceptable level of 
quality before they were included in the analysis.  
 
VGC analysis 
 The VGC method of Bath and Mansson (21) was used to illustrate viewer assessment 
of image quality based on the visibility of normal anatomy. Specifically, for this work, the 
presence of contrast media filling was recorded for pulmonary arterial system using a five-
point classification scale where score 1 indicated no contrast media filling within the 
pulmonary vasculature and 5 represented complete filling. 
 
Inter- and intra-reader variability 
The inter- and intra-observer agreements were calculated using Cohen κ analysis. A k 
value 0.60 to 1, 0.41 to 0.60, 0.21 to 0.40, and less than 0.20 was considered excellent, 
moderate, fair, and poor agreement, respectively. 
 
Statistical Analysis 
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  Continuous variables were described with mean ± standard deviation (SD). The 
analysis of variance (ANOVA) was used to compare the means across the tertiles of contrast 
volume.  The association between contrast volume and measured variables was evaluated 
through simple linear regression. Analyses were conducted using SPSS 22 for Windows (SPSS 
Inc, Chicago, IL). Results were considered statistically significant if p≤0.05 with a 95% 
confidence interval and a power of 0.8. ROC and VGC were employed to measure the 
confidence intervals in pathology detection and image quality respectively.  Jackknife Free-
response (JAFROC) assessment of diagnostic systems continues to gain acceptance in areas 
related to the detection, localization and classification of one or more “abnormalities” 
within a subject.  
 
Results 
Patient Demographics 
There was no significant change in CMV with gender and age, however, CMV 
increased with increasing body weight (p<0.004) and BMI (p<0.01) (Table 1).  Additionally, 
the effective radiation dose also increased from low contrast media volumes (0-10mL) to 
higher contrast media volumes (60-70 mL) (p<0.03) incrementally. 
Table 1: patient demographics 
Patient 
Parameters 
Contrast Volume Range (mL) 
0-10 10-20 20-30 30-40 40-50 50-60 60-70 
P 
value 
Male 0 3 9 63 15 8 1 
> 
0.096 
Female 2 3 5 39 29 20 3 
> 
0.338 
Total 2 6 14 102 44 28 4 
> 
0.077 
Age (years)* 
51.23±11.
23 
64 ± 
19.83 
67 ± 
18.34 
42 ± 
12.24 
48 ± 
19.67 
55 ± 
42.28 
59 ± 
23.22 
> 
0.068 
Height (cm)* 
172.16 ± 
2.13 
167 ± 
18.51 
181 ± 
24.33 
177± 
48.73 
182 ± 
13.11 
173 ± 
26.41 
175 ± 
9.77 
> 
0.078 
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Weight (kg)* 51 ± 9.12 
52 ± 
13.81 
58 ± 
33.18 
73 ± 
16.81 
75 ± 
12.93 
81 ± 
22.67 
82 ± 
13.46 
< 
0.004 
BMI (kg/m2) 
25.32 ± 
8.22 
24 ± 
6.67 
25 ± 
3.89 
26 ± 
4.38 
25 ± 
9.22 
27 ± 
4.54 
27 ± 
9.91 
< 
0.01 
Scan Time 
(sec) 
3.22 ± 1.2 
3.77 ± 
1.9 
3.99 ± 
1.4 
4.11 ± 
1.1 
4.21 ± 
1.7 
4.38 ± 
0.9 
4.39 ± 
0.7 
> 
0.066 
Scan Range 
(cm)  
52.12 ± 
1.07 
52.54 ± 
1.78 
53.17 ± 
1.81 
53.48 ± 
3.22 
53.71 ± 
4.91 
53.91 ± 
4.03 
54.16 ± 
3.12 
> 
0.067 
Eff Dose 
(mSv) 
2.41 ± 
0.62 
2.46 ± 
1.47 
2.59 ± 
0.75 
2.79 ± 
1.13 
3.19 ± 
0.44 
3.59 ± 
0.49 
3.91 ± 
0.22 
< 
0.003 
Note – Data are mean ± standard deviation, p<0.05, statistically significant with ANOVA 
 
Image acquisition and contrast media volume 
There was no statistical significance in mean scan time in each contrast range; 0-10 
mL: (3.22 ± 1.2 sec) compared to 60-70 mL: (4.39 ± 1.3 sec), (p>0.05)(Table 1).  All patients 
tolerated their assigned contrast material delivery protocol without any related 
complication. 
 
Quantitative Analysis 
 The mean pulmonary arterial opacification of the main pulmonary circulation was 
(343.88±73HU). For the right lung, the mean arterial opacification was: upper lobe 
(316.51±23HU), middle lobe (312.5±39HU) and lower lobe (315.23±65HU). For the left lung, 
the mean arterial opacification was: upper lobe (318.76±83HU) and lower lobe 
(321.91±12HU) (Table 2).  The mean venous opacification of all pulmonary veins was below 
the threshold of 182±72HU (Table 2).  Additionally, opacification of the superior vena cava 
veins was approximatly double that of the mean pulomnary artery opacification.  The AVCR 
ranged from 2.21:1 to 3.83:1 (p<0.0010) which demonstrated significant difference between 
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arterial and venous opacification (Table 3). 
 
Table 2: Mean opacification (HU) of arteries and veins at each anatomical segment during 
CTPA. 
 Anatomical 
Location 
Mean 
Opacification 
with SD 
 
 
 
Pulmonary Trunk 
     Right main pulmonary artery 
     Left main pulmonary artery 
 
Atrial Vein 
    Right superior 
    Right inferior 
    Left superior 
    Left inferior  
 
Superior vena cava 
 
Pulmonary Arteries 
      Right superior anterior  
      Right superior posterior  
      Right medial 
      Right lateral 
      Right anterior-basal 
      Right posterior-basal 
    
      Left apico-posterior 
      Left inferior lingular 
      Left anteromedial basal 
      Left posterior-basal 
   
Pulmonary Veins 
       Right superior anterior 
       Right superior posterior 
       Right medial 
       Right lateral 
       Right anterior-basal 
       Right posterior-basal 
        
       Left apico-posterior  
       Left inferior lingular 
       Left anteromedial basal 
       Left posterior-basal 
 
Mediastinum 
 
 
 
Mediastinum 
 
 
 
 
 
 
 
 
Right upper 
lobe 
 
Right middle 
lobe 
 
Right lower 
lobe 
 
 
Left upper 
lobe 
 
Left lower lobe 
 
 
 
Right upper 
lobe 
 
Right middle 
lobe 
 
Right lower 
lobe 
 
     362  ±   97 
      337  ±   88 
      323  ±   88 
 
 
     177  ±   73 
     154  ±   67 
     182  ±   72 
     157  ±   61 
 
      606  ± 257 
    
    
      320  ±  87 
      313  ±  83 
      311  ±  93 
      314  ±  86 
      306  ±  89 
      325  ±  95 
 
      314  ±   79 
      323  ±   86 
      319  ±   82 
      323  ±   83 
 
 
      112  ±   79 
      122  ±   78 
        95  ±   62 
      101  ±   60 
        92  ±   61 
        96  ±   59 
 
      141  ±   80    
      146  ±   77 
      120  ±   61 
      111  ±   62 
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Left upper 
lobe 
 
Left lower lobe 
   
Note—Data are mean ± standard deviation (SD), p<0.05, statistically significant with ANOVA 
 
 17 
 
Table 3: Mean opacification (HU) profile of artery and vein at each anatomical level 
and the ratio of the AVCR.  
Anatomical 
 
Anatomical   
 
Level Location   Artery       Vein      Ratio    P value 
 
Right superior 
anterior 
Right superior 
posterior 
 
Right medial 
Right lateral 
 
Right anterior-basal 
Right posterior-
basal 
 
Left apico-posterior 
Left inferior lingular 
 
Left anteromedial 
basal 
Left posterior-basal 
 
Right Upper 
Lobe 
 
 
Right Middle 
Lobe 
 
 
Right Lower 
Lobe 
 
 
Left Upper Lobe 
 
 
Left Lower Lobe 
 
320 ± 87       112 ± 79     
2.86 
313 ± 83       122 ± 78     
2.65 
         
311 ± 93         95 ± 62     
3.27 
314 ± 86       101 ± 60     
3.10 
 
306 ± 89         92 ± 61     
3.33 
325 ± 95         96 ± 59     
3.38 
 
314 ± 79       141 ± 80     
2.23 
323 ± 86       146 ± 77     
2.21 
         
319 ± 82       120 ± 61     
2.66 
323 ± 83       111 ± 62     
2.91 
 
 
<0.0001 
<0.0001 
 
<0.0001 
<0.0001 
 
<0.0001 
<0.0001 
 
  0.0002 
  0.0002 
 
<0.0001 
<0.0001 
   
Note—Data are mean ± standard deviation, p<0.05, statistically significant with ANOVA 
 
 
Lung Volume vs. Contrast volume in patient specific contrast formula 
When employing the patient-specific formula, increase in CMV positively 
correlated with increased total lung volume (r =0.89, p< 0001).  As expected, total lung 
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volume increased with increasing mean anteroposterior and lateral lung diameters.  
Therefore, increased lung volume, anteroposterior, and lateral chest diameters are 
correlated with increased CMV (Table 4).  
 
Table 4: Mean lung volumes (mL), contrast media (mL) and chest diameters (mm). 
Note – Data are mean (±) indicate the standard deviation 
 
 
 
CMV Range 
(mL) 
RLV (mL) Left LV 
(mL) 
Total LV (mL) Total LV per 
CM (mL) 
Mean AP 
Diameter 
(mm) 
Mean LAT 
Diameter 
(mm) 
    
 
0 – 10 (2) 
 
10 – 20 (6) 
 
20 – 30 (14) 
 
30 – 40 
(102) 
 
40 – 50 (44) 
 
50 – 60 (28) 
 
60 – 70 (4) 
 
1482.71 ± 
32.52 
 
1593.86 ± 
47.11 
 
1618.13 ± 
19.83 
 
1690.44 ± 
33.69 
 
1809.5 ± 59.85 
 
2305.5 ± 55.52 
 
2403.8 ± 42.16 
 
1367.97 ± 
53.42 
 
1358.22 ± 
81.34 
 
1575.92 ± 
63.19 
 
1745.14 ± 
28.12 
 
2110.22 ± 31.6 
 
1857.50 ± 45.5 
 
1798.14 ± 31.9 
 
2849.97 ± 
46.12 
 
2951.22 ± 
62.28 
 
3193.92 ± 
48.19 
 
3435.14 ± 
29.73 
 
3919.46 ± 
32.81 
 
4162.10 ± 
52.57 
 
4201.08 ± 
13.22 
 
569.34 ± 
31.19 
 
196.18 ± 
28.03 
 
127.63 ± 
16.18 
 
98.17 ± 
11.28 
 
87.04 ± 
15.32 
 
69.38 ± 
03.12 
 
64.63 ± 
02.29 
 
265.37 ± 
09.12 
 
277.16 ± 
19.87 
 
283.44 ± 
16.11 
 
302.21 ± 
19.19 
 
306.57 ± 
28.45 
 
322.28 ± 
16.32 
 
329.10 ± 
22.58 
 
185.18 ± 
13.02 
 
193.27 ± 
68.41 
 
198.22 ± 
17.61 
 
208.38 ± 
19.76 
 
217.26 ± 
28.32 
 
225.18 ± 
29.22 
 
231.92 ± 
18.47 
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However, we further stratified CMV groups into tertiles (3 groups) to equally 
distribute the number of patients across each group unlike in table 4.  Regression 
analysis was performed for each CMV group relative to lung volume.  By comparing 
CMV 1(< 32mL) and 2 (>33 - <50 mL) demonstrated significant changes in the right and 
left lungs (p<0.006) (Table 5). Also, when comparing group 2 (>37 - <40 mL) with group 3 
(> 41mL), statistical significance was seen with increasing lung volumes in both right and 
left lung (p<0.001) as well as an increase in effective radiation dose (p<0.04) (Table 5).  
Interestingly, after regression analysis was performed, weight and BMI had no statistical 
significance association with increased lung volume and CMV. 
 
Table 5:  Contrast media volume ranges 
Note – (±) indicate the standard deviation, p<0.05, statistically significant with ANOVA 
 
 
Qualitative Analysis 
Visual grading characteristic - the scores were individually graded by the two 
   Contrast Media Volume Range (mL)  
  All <32           33 to 40 >41 
P-value 
  (n =200) (n = 60) (n = 81) (n = 59) 
Right Lung Volume 1843.42 ± 39.67 1564.91 ± 38.31 1749.96 ± 43.82 2354.65 ± 98.23 0.007 
Left Lung Volume 1687.59 ± 59.17 1434.38 ± 29.76 1927.68 ± 14.09 1827.82 ± 60.64 0.006 
Total Lung Volume 3530.41 ± 98.36 2998.65 ± 47.23 3677.39 ± 102.44 4181.59 ± 130.05 0.001 
Weight 78.91 ± 14.78 78.79 ± 16.87 77.76 ± 14.83 80.25 ± 12.48 0.561 
Height 1.71 ± 0.09 1.69 ± 0.09 1.72 ± 0.08 1.72 ± 0.09 0.383 
Body Mass Index 27.07 ± 4.67 27.53 ± 5.20 26.31 ± 4.16 27.37 ± 4.62 0.383 
Anteroposterior Length 298.11 ± 32.64 275.33 ± 32.17 304.05 ± 33.88 286.69 ± 30.90 0.08 
Lateral Length 208.48 ± 33.15 192.23 ± 33.15 212.82 ± 34.99 201.55 ± 38.24 0.08 
Dose Length Product 163.90 ± 49.22 178.83 ± 61.93 188.38 ± 40.09 164.44 ± 38.71 0.08 
Effective Dose 2.31 ± 0.74 1.89 ± 0.93 2.13 ± 0.60 2.60 ± 0.58 0.04 
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readers (R1 and R2) and were expressed as a graph (Figure 3).  The sensitivity and 
specificity were then compared by calculating the area under the curve (AUC) 
differences from each of the ROC curve analysis. Calculating the difference between 
each reader, the graphs demonstrated an AUC=0.831, with a 95% confidence interval of 
0.71-0.89 (p<0.02). 
 
Jacknife free response receiver operating characteristic – the six-point scale 
demonstrated a significant difference (p<0.001) between protocols with mean ROC 
values demonstrating strong reader confidence between each CMV range (95%CI 0.88-
0.99) (figure 4). The number of patient diagnosed with PE was 38 (19%).  Kappa analysis 
- CTPA yielded excellent interobserver agreement (k = 0.71) in all ranges.  There was a 
strong positive relationship between mean pulmonary arterial opacification, good image 
quality and reader confidence in the patient specific protocol (r = 0.67, p < 0.001). 
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Figure 3: Visual grading characteristic curve. The graph represents positive agreement 
in image quality during pulmonary CTA. VGC was employed to measure the confidence 
intervals in image quality assessment by radiologists. 
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Figure 4: Receiver operating characteristic curve. The graph represents significant 
sensitivity and specificity in pathology detection at all lung volumes and contrast 
volumes. ROC was employed to measure the confidence intervals in pathology 
detection by radiologists. 
 
Discussion 
 There have been considerable studies carried out to reduce radiation dose via 
reduction of radiation output, fixed CMV and reduced contrast media concentrations 
during CTA (22-24).  Additionally, weight-based contrast media protocols have been 
considerably used to perform consistent optimal image quality during CTPA, but at the 
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cost of larger CMV for considerably larger patients (25).  However, until recently, 
patient-specific protocols have not been readily employed to significantly reduce 
contrast media dose during CTPA without compromising image quality (12, 14).  
Nevertheless, to our knowledge this is the first study to investigate a possible 
relationship between CMV and lung volumes, weight and BMI and how different CMVs 
could affect confidence in emboli detection and image quality when employing a 
patient-specific formula.     
The results of this study have demonstrated a significant correlation between 
CMV and lung organ volumes. When this formula was applied to patients, the CMV 
increased with increased lung volume which might be important in order to maintain a 
good visualization of pulmonary vasculature. Also, there was no significant change in 
CMV with gender and age, however, CMV initially increased with increasing body weight 
and BMI when patient were unequally grouped into 7 protocol ranges. However when 
grouped into 3 ranges with same patient number, body weight and BMI did not 
corelated with CMV which is in contrast with previous findings (26-30).  The reduced 
CMV did not affect pulmonary artery opacification and the sensitivity and specificity of 
pulmonary emboli detection as those in previously reported papers (31-33).  
There still remain controversies surrounding the effect of CMV and increased 
radiation dose due to the photoelectric effect.  Recent studies demonstrated that the 
addition of contrast media during CT increased double DNA strand breaks which is 
attributed to increased radiation dose (34, 35).  Additionally, future studies published 
should consider the effect of iodinated contrast material on the organ doses 
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administered to patients undergoing CT, as it is important in estimating radiation dose 
(36, 37).  In our study, we demonstrated that increased lung volume was correlated with 
increased CMV as well as radiation dose, but when compared to other studies, our CMV 
range was from 10 – 76mLs and other studies from 40 – 120mLs (38-42).  Finally, a 
strong correlation between increased lung and contrast volumes, demonstrated no 
correlation with BMI.  Therefore, the radiation dose increase can be attributed to the 
increased volume in the pulmonary circulation at the time of the CTA and not patient 
weight. 
There were shortcomings in the current study.  Firstly, whilst every attempt was 
made to have uniform inspiration between patient to patient, the exact air volume 
entering the lungs could not be controlled and thus potentially the increase in blood 
volume could not be determined.  Secondly, we did not measure the effect between 
weight-based contrast media protocols and the patient-specific contrast media 
protocols in pulmonary CTA.  Finally, the main limitation of this study is the fact that it is 
a retrospective one. A randomized clinical trial will be needed to confirm our results. 
 
Conclusion 
High CMVs present a health hazard that could be avoided if patient specific 
CMVs are administered. The patient specific CMVs should preserve image quality thus 
maintaining the diagnostic relevance of their usage. A correlation between CMV and 
lung volume might be important in order to maintain a good visualization of pulmonary 
vasculature. This study showed that administering a patient tailored CMV can preserve 
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image quality. Moreover, increased CMV is significantly correlated to increased patient 
lung volume when employing a patient-specific contrast formula. The main limitations 
of this study is the fact that it is a retrospective study. A randomized clinical trial is 
needed to confirm our results.  
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